Tau protein kinases: involvement in Alzheimer's disease
Tau phosphorylation is regulated by a balance between tau kinase and phosphatase
activities. Disruption of this equilibrium was suggested to be at the origin of abnormal tau …
activities. Disruption of this equilibrium was suggested to be at the origin of abnormal tau …
A de novo convergence of autism genetics and molecular neuroscience
Autism spectrum disorder (ASD) and intellectual disability (ID) are neurodevelopmental
disorders with large genetic components, but identification of pathogenic genes has …
disorders with large genetic components, but identification of pathogenic genes has …
[HTML][HTML] A transcription factor atlas of directed differentiation
Transcription factors (TFs) regulate gene programs, thereby controlling diverse cellular
processes and cell states. To comprehensively understand TFs and the programs they …
processes and cell states. To comprehensively understand TFs and the programs they …
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
The CRISPR/Cas9 system is a robust genome editing technology that works in human cells,
animals and plants based on the RNA-programmed DNA cleaving activity of the Cas9 …
animals and plants based on the RNA-programmed DNA cleaving activity of the Cas9 …
Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders
BJ O'Roak, L Vives, W Fu, JD Egertson, IB Stanaway… - Science, 2012 - science.org
Exome sequencing studies of autism spectrum disorders (ASDs) have identified many de
novo mutations but few recurrently disrupted genes. We therefore developed a modified …
novo mutations but few recurrently disrupted genes. We therefore developed a modified …
De novo gene disruptions in children on the autistic spectrum
Exome sequencing of 343 families, each with a single child on the autism spectrum and at
least one unaffected sibling, reveal de novo small indels and point substitutions, which come …
least one unaffected sibling, reveal de novo small indels and point substitutions, which come …
A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
P Wang, JC Alvarez-Perez, DP Felsenfeld, H Liu… - Nature medicine, 2015 - nature.com
Abstract Types 1 and 2 diabetes affect some 380 million people worldwide. Both ultimately
result from a deficiency of functional pancreatic insulin-producing beta cells. Beta cells …
result from a deficiency of functional pancreatic insulin-producing beta cells. Beta cells …
Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in D own syndrome mouse models and in humans
R De la Torre, S De Sola, M Pons… - Molecular nutrition & …, 2014 - Wiley Online Library
Scope Trisomy for human chromosome 21 results in D own syndrome (DS), which is among
the most complex genetic perturbations leading to intellectual disability. Accumulating data …
the most complex genetic perturbations leading to intellectual disability. Accumulating data …
The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation
LP Van Der Heide, MFM Hoekman… - Biochemical …, 2004 - portlandpress.com
FoxO (forkhead box O; forkhead members of the O class) are transcription factors that
function under the control of insulin/insulin-like signalling. FoxO factors have been …
function under the control of insulin/insulin-like signalling. FoxO factors have been …
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
JR Arron, MM Winslow, A Polleri, CP Chang, H Wu… - Nature, 2006 - nature.com
Trisomy 21 results in Down's syndrome, but little is known about how a 1.5-fold increase in
gene dosage produces the pleiotropic phenotypes of Down's syndrome. Here we report that …
gene dosage produces the pleiotropic phenotypes of Down's syndrome. Here we report that …